Eliem Therapeutics (ELYM) Rallies As Acquisition Propels Investor Optimism
Shares of Eliem Therapeutics, Inc. (NASDAQ: ELYM) have embarked on a bullish trajectory this morning, marking a substantial increase of 53.93% to reach $4.11 as per the latest check. This upsurge comes in the wake of an announcement regarding an acquisition through an equity maneuver, consequently boosting investor confidence in ELYM shares. Eliem (ELYM) has […]
